ReviewBreathe (Sheffield, England)2026
Understanding neuro-pulmonary dysfunction in children with neurodisability.
Review in Breathe (Sheffield, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Children with neurodisability experience a high burden of respiratory morbidity, which remains a leading cause of hospitalisation, long-term lung disease and reduced quality of life. Respiratory problems in this population often reflect shared underlying neuro-pulmonary pathophysiology that evolves across a child's development. In this narrative review, we describe how respiratory vulnerability arises from three interacting domains: dysregulated central control of breathing; impaired neuromuscular activation and coordination; and altered respiratory mechanics related to abnormal tone, weakness, posture and chest wall restriction. Early functional impairment in these systems compromises ventilation, airway protection and airway clearance, establishing baseline respiratory vulnerability. Over time, secondary clinical features such as sleep disordered breathing, pulmonary aspiration, secretion retention and recurrent infection may come to dominate the respiratory phenotype and contribute to progressive lung injury, including restrictive lung disease and bronchiectasis. We synthesised evidence linking neuro-pulmonary mechanisms to clinical presentations and highlight challenges in assessment where standard investigations are limited. By integrating mechanistic understanding with history-led clinical reasoning, we identify opportunities for proactive, anticipatory respiratory care across childhood and during the transition to adult services. This review aims to support earlier recognition of respiratory risk factors and to promote pathophysiology-informed strategies to preserve long-term respiratory health in children with neurodisability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.